Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: Role for open reading frame 61 as a modulator of NF-κB activity

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 1193-1202

  Sloan, Elizabeth ^a,b   Henriquez, Rodney ^a,b   Kinchington, Paul R ^c   Slobedman, Barry ^a,b   Abendroth, Allison ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UBIQUITIN PROTEIN LIGASE E3;

ADULT; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; VARICELLA ZOSTER VIRUS; WESTERN BLOTTING;

CELL LINE; DENDRITIC CELLS; DOWN-REGULATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; NF-KAPPA B; OPEN READING FRAMES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 84856876324     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06400-11     Document Type: Article

References (35)

1. Abendroth A, Kinchington PR, Slobedman B. 2010. Varicella-zoster virus immune evasion strategies. Curr. Top. Microbiol. Immunol. 342: 155-171.
2. Abendroth A, Morrow G, Cunningham AL, Slobedman B. 2001. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J. Virol. 75: 6183-6192.
3. Amici C, et al. 2006. Herpes simplex virus disrupts NF-κB regulation by blocking its recruitment on the IκBκ promoter and directing the factor on viral genes. J. Biol. Chem. 281:7110-7117.
4. Baldwin AS, Jr. 1996. The NF-κB and I κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
5. Beg AA, Baldwin AS, Jr. 1993. The I κB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
6. Blackwell TS, Christman JW. 1997. The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:3-9.
7. Bour S, Perrin C, Akari H, Strebel K. 2001. The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with beta TrCP-mediated degradation of IκB. J. Biol. Chem. 276: 15920-15928.
8. Cohen JI, Nguyen H. 1998. Varicella-zoster virus ORF61 deletion mutants replicate in cell culture, but a mutant with stop codons in ORF61 reverts to wild-type virus. Virology 246:306-316.
9. Daubeuf S, et al. 2009. HSV ICP0 recruits USP7 to modulate TLRmediated innate response. Blood 113:3264-3275.
10. Diao L, et al. 2005. Herpesvirus proteins ICP0 and BICP0 can activate NF-κB by catalyzing IκBκ ubiquitination. Cell. Signal. 17:217-229.
11. Eisfeld AJ, Yee MB, Erazo A, Abendroth A, Kinchington PR. 2007. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms. J. Virol. 81:9034-9049.
12. Foo SY, Nolan GP. 1999. NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet. 15:229-235.
13. Ghosh S, Karin M. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl):S81-S96.
14. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
15. Hood C, Cunningham AL, Slobedman B, Boadle RA, Abendroth A. 2003. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J. Virol. 77:12852-12864.
16. Huch JH, et al. 2010. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J. Virol. 84:4060-4072.
17. Jones JO, Arvin AM. 2006. Inhibition of the NF-κB pathway by varicellazoster virus in vitro and in human epidermal cells in vivo. J. Virol. 80: 5113-5124.
18. Kinchington PR, Vergnes JP, Turse SE. 1995. Transcriptional mapping of varicella-zoster virus regulatory proteins. Neurology 45:S33-S35.
19. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem. 267: 24157-24160.
20. Miranda-Saksena M, Armati P, Boadle RA, Holland DJ, Cunningham AL. 2000. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J. Virol. 74:1827-1839.
21. Moriuchi H, Moriuchi M, Smith HA, Straus SE, Cohen JI. 1992. Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J. Virol. 66:7303-7308.
22. Morrow G, Slobedman B, Cunningham AL, Abendroth A. 2003. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol. 77:4950-4959.
23. Moutaftsi M, Brennan P, Spector SA, Tabi Z. 2004. Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J. Virol. 78: 3046-3054.
24. Patel A, et al. 1998. Herpes simplex type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication. Virology 247:212-222.
25. Rahaus M, Desloges N, Wolff MH. 2005. ORF61 protein of varicellazoster virus influences JNK/SAPK and p38/MAPK phosphorylation. J. Med. Virol. 76:424-433.
26. Rahman MM, McFadden G. 2011. Modulation of NF-κB signalling by microbial pathogens. Nat. Rev. Microbiol. 9:291-306.
27. Stewart S, et al. 2004. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway. Proc. Natl. Acad. Sci. U. S. A. 101:15730-15735.
28. Sylla BS, et al. 1998. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-κB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ. Proc. Natl. Acad. Sci. U. S. A. 95:10106-10111.
29. Vallabhapurapu S, Karin M. 2009. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27: 693-733.
30. Van Tendeloo VF, et al. 2001. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing ofmRNAand to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49-56.
31. Walters MS, Kyratsous CA, Silverstein SJ. 2010. The RING finger domain of varicella-zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient auto-ubiquitination and dispersion of Sp100 containing nuclear bodies. J. Virol. 84:6861-6865.
32. Wang L, et al. 2011. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog. 7:e1002157.
33. Wang L, Sommer M, Rajamani J, Arvin AM. 2009. Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis. J. Virol. 83:7560-7572.
34. Yurochko AD, Kowalik TF, Huong SM, Huang ES. 1995. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
35. Zhu H, et al. 2011. Varicella-zoster virus immediate early protein ORF61 abrogates IRF3-mediated innate immune response through degradation of activated IRF3. J. Virol. 85:11079-11089.